| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 53.3507 | 57 |
| GSM780708 | Untreated after 4 days (C2_1) | 48.2763 | 42 |
| GSM780709 | Untreated after 4 days (C3_1) | 44.8438 | 26 |
| GSM780719 | Untreated after 4 days (C1_2) | 42.579 | 16 |
| GSM780720 | Untreated after 4 days (C2_2) | 40.7685 | 9 |
| GSM780721 | Untreated after 4 days (C3_2) | 45.9111 | 32 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 50.4267 | 50 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 52.6777 | 55 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 51.3053 | 52 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 42.8687 | 17 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 45.5497 | 30 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 47.6899 | 40 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 44.0234 | 22 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 43.7582 | 21 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 42.0297 | 13 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 45.2507 | 28 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 49.603 | 47 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 47.2501 | 38 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 41.9901 | 13 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 42.4549 | 15 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 47.6966 | 40 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 44.068 | 22 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 48.8516 | 44 |